Blockchain technology has been explored as a solution for pharmaceutical supply chain transparency and anti-counterfeiting. While blockchain has not been widely adopted as the primary infrastructure for drug traceability (EPCIS-based systems are more prevalent), it offers specific advantages for multi-party data sharing and immutable audit trails.
Blockchain Applications in Pharma
Key pharmaceutical blockchain use cases include: supply chain provenance tracking (recording each custody transfer on an immutable ledger); clinical trial data integrity (ensuring trial data cannot be altered retroactively); drug recall management (rapidly identifying affected products and their locations); and counterfeit detection (verifying product authenticity against blockchain records).
DSCSA and Blockchain
Several pharmaceutical companies and technology providers have piloted blockchain-based DSCSA interoperability networks. The MediLedger Network is the most prominent example, using a permissioned blockchain to enable DSCSA-compliant data exchange between trading partners. The FDA has acknowledged blockchain as a potential DSCSA interoperability solution.
Limitations
Blockchain faces several limitations in pharmaceutical supply chain applications: scalability (high transaction volumes can strain blockchain networks); data privacy (all participants can see all data on a public blockchain); integration complexity (legacy systems must be updated to write to the blockchain); and governance (permissioned blockchains require agreement on governance rules among all participants).